Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 4, 2014, Pages 373-380

  Sharp, Sally I ^a   Mcquillin, Andrew ^a   Marks, Michael ^a   Hunt, Stephen P ^a   Stanford, S Clare ^a   Lydall, Greg J ^a   Morgan, Marsha Y ^a   Asherson, Philip ^b   Curtis, David ^a   Gurling, Hugh M D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Affective disorders; Alcohol dependence; Bipolar disorder; Mutation; Replication; Susceptibility; Tachykinin receptor

Indexed keywords

DNA; NEUROKININ 1 RECEPTOR; SUBSTANCE P; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALCOHOLISM; ALTERNATIVE RNA SPLICING; ARTICLE; ATTENTION DEFICIT DISORDER; BINDING AFFINITY; BIPOLAR DISORDER; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MOOD DISORDER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; REPRODUCIBILITY;

ALCOHOLISM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NEUROKININ-1; REPRODUCIBILITY OF RESULTS;

EID: 84901587035     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32241     Document Type: Article

References (54)

1. 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467: (7319):1061-1073.
2. Angst J, Gamma A, Endrass J, Rossler W, Ajdacic-Gross V, Eich D, Herrell R, Merikangas KR. 2006. Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder? Eur Arch Psychiatry Clin Neurosci 256(7):452-457.
3. Bertelsen A, Harvald B, Hauge M. 1977. A Danish twin study of manic-depressive disorders. Br J Psychiatry 130:330-351.
4. Blaine S, Claus E, Harlaar N, Hutchison K. 2013. TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol Clin Exp Res 37(Suppl 1):E125-E130.
5. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr, Reich T, Schmidt I, Schuckit MA. 1994. A new, semi-structured psychiatric interview for use in genetic linkage studies: A report on the reliability of the SSAGA. J Stud Alcohol 55(2):149-158.
6. Caberlotto L, Hurd YL, Murdock P, Wahlin JP, Melotto S, Corsi M, Carletti R. 2003. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur J Neurosci 17(9):1736-1746.
7. Chandra P, Hafizi S, Massey-Chase RM, Goodwin GM, Cowen PJ, Harmer CJ. 2010. NK1 receptor antagonism and emotional processing in healthy volunteers. J Psychopharmacol 24(4):481-487.
8. Commons KG. 2009. Neuronal pathways linking substance P to drug addiction and stress. Brain Res 1314:175-182.
9. Datta SR, McQuillin A, Rizig M, Blaveri E, Thirumalai S, Kalsi G, Lawrence J, Bass NJ, Puri V, Choudhury K, Pimm J, Crombie C, Fraser G, Walker N, Curtis D, Zvelebil M, Pereira A, Kandaswamy R, St Clair D, Gurling HM. 2010. A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Mol Psychiatry 15(6):615-628.
10. Dedman A, McQuillin A, Kandaswamy R, Sharp S, Anjorin A, Gurling H. 2012. Sequencing of the ANKYRIN 3 gene (ANK3) encoding ankyrin G in bipolar disorder reveals a non-conservative amino acid change in a short isoform of ankyrin G. Am J Med Genet B Neuropsychiatr Genet 159B(3):328-335.
11. Dick DM, Nurnberger J Jr, Edenberg HJ, Goate A, Crowe R, Rice J, Bucholz KK, Kramer J, Schuckit MA, Smith TL, et al. 2002. Suggestive linkage on chromosome 1 for a quantitative alcohol-related phenotype. Alcohol Clin Exp Res 26(10):1453-1460.
12. Ebner K, Sartori SB, Singewald N. 2009. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des 15(14):1647-1674.
13. Edwards AC, Kendler KS. 2012. Twin study of the relationship between adolescent attention-deficit/hyperactivity disorder and adult alcohol dependence. J Stud Alcohol Drugs 73(2):185-194.
14. Edwards AC, Aliev F, Bierut LJ, Bucholz KK, Edenberg H, Hesselbrock V, Kramer J, Kuperman S, Nurnberger JI Jr, Schuckit MA, Porjesz B, Dick DM. 2012. Genome-wide association study of comorbid depressive syndrome and alcohol dependence. Psychiatr Genet 22(1):31-41.
15. ENCODE Project Consortium. 2011. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9(4):e1001046.
16. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. 2002. Predictive identification of exonic splicing enhancers in human genes. Science 297(5583):1007-1013.
17. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9):1056-1058.
18. Fong TM, Anderson SA, Yu H, Huang RR, Strader CD. 1992. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol 41(1):24-30.
19. George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M. 2008. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319(5869):1536-1539.
20. Goldstein BI, Herrmann N, Shulman KI. 2006. Comorbidity in bipolar disorder among the elderly: Results from an epidemiological community sample. Am J Psychiatry 163(2):319-321.
21. Guerrini I, Cook CC, Kest W, Devitgh A, McQuillin A, Curtis D, Gurling HM. 2005. Genetic linkage analysis supports the presence of two susceptibility loci for alcoholism and heavy drinking on chromosome 1p22.1-11.2 and 1q21.3-24.2. BMC Genet 6:11.
22. Hafizi S, Chandra P, Cowen J. 2007. Neurokinin-1 receptor antagonists as novel antidepressants: Trials and tribulations. Br J Psychiatry 191:282-284.
23. Howie BN, Donnelly P, Marchini J. 2009. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5(6):e1000529.
24. Howie B, Marchini J, Stephens M. 2011. Genotype imputation with thousands of genomes. G3 (Bethesda) 1(6):457-470.
25. Lappalainen J, Kranzler HR, Petrakis I, Somberg LK, Page G, Krystal JH, Gelernter J. 2004. Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus. Mol Psychiatry 9(3):312-319.
26. Lydall GJ, Bass NJ, McQuillin A, Lawrence J, Anjorin A, Kandaswamy R, Pereira A, Guerrini I, Curtis D, Vine AE, Sklar P, Purcell SM, Gurling HM. 2011. Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder. Psychiatr Genet 21(6):294-306.
27. Maggi CA. 1995. The mammalian tachykinin receptors. Gen Pharmacol 26(5):911-944.
28. Mantere O, Suominen K, Valtonen HM, Arvilommi P, Leppamaki S, Paunio T, Isometsa ET. 2012. Concomitants of family histories of mood disorders and alcoholism in a clinical cohort of patients with bipolar I and II disorder. J Nerv Ment Dis 200(5):388-394.
29. Marchini J, Howie B. 2010. Genotype imputation for genome-wide association studies. Nat Rev Genet 11(7):499-511.
30. McCabe C, Cowen PJ, Harmer CJ. 2009. NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers. Int J Neuropsychopharmacol 12(9):1261-1274.
31. McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the Opcrit system. Arch Gen Psychiatry 48(8):764-770.
32. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. 2010. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. BMC Bioinformatics 26(16):2069-2070.
33. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. 2011. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241-251.
34. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, Nguyen TT, Schafer H, Holmans P, Daly M, Steinhausen HC, Freitag C, Reif A, Renner TJ, Romanos M, Romanos J, Walitza S, Warnke A, Meyer J, Palmason H, Buitelaar J, Vasquez AA, Lambregts-Rommelse N, Gill M, Anney RJ, Langely K, O'Donovan M, Williams N, Owen M, Thapar A, Kent L, Sergeant J, Roeyers H, Mick E, Biederman J, Doyle A, Smalley S, Loo S, Hakonarson H, Elia J, Todorov A, Miranda A, Mulas F, Ebstein RP, Rothenberger A, Banaschewski T, Oades RD, Sonuga-Barke E, McGough J, Nisenbaum L, Middleton F, Hu X, Nelson S. 2010. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49(9):884-897.
35. Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL, Henders AK, Wallace L, Todorov AA, Schrage AJ, Saccone NL, Madden PA, Degenhardt L, Martin NG, Montgomery GW. 2013. ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: Importance of considering drug exposure. JAMA Psychiatry 70(3):325-333.
36. Pereira AC, McQuillin A, Puri V, Anjorin A, Bass N, Kandaswamy R, Lawrence J, Curtis D, Sklar P, Purcell SM, Gurling HM. 2011. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 156(2):177-187.
37. Perlis RH, Purcell S, Fagerness J, Kirby A, Petryshen TL, Fan J, Sklar P. 2008. Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry 65(1):53-61.
38. Rupniak NM, Jackson A. 1994. Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99, 994 in guinea-pigs. Eur J Pharmacol 262(1-2):171-175.
39. Schank JR, Tapocik JD, Barbier E, Damadzic R, Eskay RL, Sun H, Rowe KE, King CE, Yao M, Flanigan ME, Solomon MG, Karlsson C, Cheng K, Rice KC, Heilig M. 2013. Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats. Biol Psychiatry 73(8):774-781.
40. Schug J. 2008. Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics, Chapter 2:Unit 2.6.
41. Seneviratne C, Ait-Daoud N, Ma JZ, Chen G, Johnson BA, Li MD. 2009. Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence. Neuropsychopharmacology 34(11):2442-2449.
42. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM. 2008. Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6):558-569.
43. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, Edenberg HJ, Nurnberger JI Jr, Rietschel M, Blackwood D, Corvin A, Flickinger M, Guan W, Mattingsdal M, McQuillin A, Kwan P, Wienker TF, Daly M, Dudbridge F, Holmans PA, Lin D, Burmeister M, Greenwood TA, Hamshere ML, Muglia P, Smith EN, Zandi PP, Nievergelt CM, McKinney R, Shilling PD, Schork NJ, Bloss CS, Foroud T, Koller DL, Gershon ES, Liu C, Badner JA, Scheftner WA, Lawson WB, Nwulia EA, Hipolito M, Coryell W, Rice J, Byerley W, McMahon FJ, Schulze TG, Berrettini W, Lohoff FW, Potash JB, Mahon PB, McInnis MG, Zollner S, Zhang P, Craig DW, Szelinger S, Barrett TB, Breuer R, Meier S, Strohmaier J, Witt SH, Tozzi F, Farmer A, McGuffin P, Strauss J, Xu W, Kennedy JL, Vincent JB, Matthews K, Day R, Ferreira MA, O'Dushlaine C, Perlis R, Raychaudhuri S, Ruderfer D, Hyoun PL, Smoller JW, Li J, Absher D, Thompson RC, Meng FG, Schatzberg AF, Bunney WE, Barchas JD, Jones EG, Watson SJ, Myers RM, Akil H, Boehnke M, Chambert K, Moran J, Scolnick E, Djurovic S, Melle I, Morken G, Gill M, Morris D, Quinn E, Muhleisen TW, Degenhardt FA, Mattheisen M, Schumacher J, Maier W, Steffens M, Propping P, Nothen MM, Anjorin A, Bass N, Gurling H, Kandaswamy R, Lawrence J, McGhee K, McIntosh A, McLean AW, Muir WJ, Pickard BS, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Jones IR, Kirov G, Moskvina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Williamson R, Young AH, Ferrier IN, Stefansson K, Stefansson H, Thornorgeirsson T, Steinberg S, Gustafsson O, Bergen SE, Nimgaonkar V, Hultman C, Landen M, Lichtenstein P, Sullivan P, Schalling M, Osby U, Backlund L, Frisen L, Langstrom N, Jamain S, Leboyer M, Etain B, Bellivier F, Petursson H, Sigurdsson E, Muller-Mysok B, Lucae S, Schwarz M, Schofield PR, Martin N, Montgomery GW, Lathrop M, Oskarsson H, Bauer M, Wright A, Mitchell PB, Hautzinger M, Reif A, Kelsoe JR, Purcell SM. 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43(10):977-983.
44. Spitzer R, Endicott J. editors. 1977. The schedule for affective disorder and schizophrenia, lifetime version. 3rd edition. New York: New York State Psychiatric Institute.
45. Spitzer RL, Andreasen NC, Endicott J. 1978. Schizophrenia and other psychotic disorders in DSM-III. Schizophr Bull 4(4):489-510.
46. Staden R. 1996. The Staden sequence analysis package. Mol Biotechnol 5(3):233-241.
47. Steensland P, Simms JA, Nielsen CK, Holgate J, Bito-Onon JJ, Bartlett SE. 2010. The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol. PLoS ONE 5(9):e12527.
48. Thorsell A, Schank JR, Singley E, Hunt SP, Heilig M. 2010. Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice. Psychopharmacology (Berl) 209(1):103-111.
49. Tuithof M, ten Have, M, van den Brink W, Vollebergh W, de Graaf R. 2012. The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2. Drug Alcohol Depend 123(1-3):115-121.
50. Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD. 2009. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol 30(6):271-276.
51. Wang M, Marin A. 2006. Characterization and prediction of alternative splice sites. Gene 366:219-227.
52. Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, Biederman J. 2011. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 50(6):543-553.
53. Yan TC, Hunt SP, Stanford SC. 2009. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: A model of attention deficit hyperactivity disorder. Neuropharmacology 57(7-8):627-635.
54. Yan TC, McQuillin A, Thapar A, Asherson P, Hunt SP, Stanford SC, Gurling H. 2010. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD. J Psychopharmacol 24(1):27-38.